Eurasian Harm Reduction Association (EHRA) is a non-for-profit public membership-based organisation, registered by the initiative of harm reduction activists and organisations from Central and Eastern Europe and Central Asia (CEECA) in 2017.

We strive for a progressive human rights-based drug policy, sustainable funding advocacy and quality of harm reduction services oriented on needs of people who use drugs.


Baltics, Central Europe, South-Eastern Europe, European Countries of the Commonwealth of Independent States, Caucasus, Russia, Central Asia


Albania, Armenia, Azerbaijan, Belarus, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Hungary, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan


Association is a membership based network. Nowadays the Association includes 214 members from CEECA region

EHRA announces a General Meeting of Members
On 13–27 November, 2017 Eurasian Harm Reduction Association (EHRA) conducts General Meeting of it’s members. During the fortnight, members of EHRA will have online-voting for four main issues: 1. Approval of EHRA Statute 2. Approval of EHRA Strategic Framework for 2018-2019 3. Approval of interim Steering Committee and timeline for
Read more.
Author: Eliza Kurcevic „After the New Year, for the smallest amount of marijuana – criminal liability and immense fines, „In one of Vilnius bars, police made a raid: Some of the bar visitors were scared, some were laughing“, „A young man was sentenced for the distribution of drugs, committed a
Read more.
Eurasian Harm Reduction Association (EHRA) members general assembly
Eurasian Harm Reduction Association (EHRA) (“Asociacija “Europos ir Azijos rizikos mažinimo tinklas”) announces the convocation of the members general assembly on-line in period from 13 to 27th of November 2017. General assembly suggested agenda: Approval of EHRA statute with changes and editions. Approval of EHRA strategic framework for 2018-2019 Approval of
Read more.